Nuveen Asset Management, LLC Co Diagnostics, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.16 - $9.56 $5.67 Million - $7.57 Million	-791,920 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.52 - $19.21 $838,010 - $1.89 Million	98,358 Added 14.18%	791,920 $7.56 Million
Q4 2020 Feb 16, 2021	BUY	$9.3 - $15.19 $424,786 - $693,818	45,676 Added 7.05%	693,562 $6.45 Million
Q3 2020 Nov 16, 2020	BUY	$8.24 - $30.8 $3.51 Million - $13.1 Million	425,386 Added 191.18%	647,886 $8.8 Million
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $1.66 Million - $5.21 Million	222,500 New	222,500 $4.31 Million

5.59M

67.5K

174K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $12.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.